Anticipating impact of implementing PCV20 or PCV21 vaccines for older adults in the immunisation programme for invasive pneumococcal disease, using nationwide surveillance data, Israel, 2009 to 2024.

Rieger R, Yahav D, Margalit I, Wieder-Finesod A, Azulay H, Ghanem-Zoubi N, Atamna A, Schindler Y, Abu Zayyad H, Dagan R, Regev-Yochay G, Israeli Adult Pneumococcal Invasive Disease (IAIPD) group

Open source

DOI: 10.2807/1560-7917.es.2026.31.15.2500589
Published: 2026 Apr
Container: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2807/1560-7917.es.2026.31.15.2500589,
  title = {Anticipating impact of implementing PCV20 or PCV21 vaccines for older adults in the immunisation programme for invasive pneumococcal disease, using nationwide surveillance data, Israel, 2009 to 2024.},
  author = {Rieger R and Yahav D and Margalit I and Wieder-Finesod A and Azulay H and Ghanem-Zoubi N and Atamna A and Schindler Y and Abu Zayyad H and Dagan R and Regev-Yochay G and Israeli Adult Pneumococcal Invasive Disease (IAIPD) group},
  year = {2026},
  journal = {Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin},
  doi = {10.2807/1560-7917.es.2026.31.15.2500589},
  url = {https://doi.org/10.2807/1560-7917.es.2026.31.15.2500589}
}

RIS

TY  - JOUR
TI  - Anticipating impact of implementing PCV20 or PCV21 vaccines for older adults in the immunisation programme for invasive pneumococcal disease, using nationwide surveillance data, Israel, 2009 to 2024.
AU  - Rieger R
AU  - Yahav D
AU  - Margalit I
AU  - Wieder-Finesod A
AU  - Azulay H
AU  - Ghanem-Zoubi N
AU  - Atamna A
AU  - Schindler Y
AU  - Abu Zayyad H
AU  - Dagan R
AU  - Regev-Yochay G
AU  - Israeli Adult Pneumococcal Invasive Disease (IAIPD) group
PY  - 2026
JO  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
DO  - 10.2807/1560-7917.es.2026.31.15.2500589
UR  - https://doi.org/10.2807/1560-7917.es.2026.31.15.2500589
ER  -

APA

R, R., D, Y., I, M., A, W., H, A., N, G., A, A., Y, S., H, A. Z., R, D., G, R., & group, I. A. P. I. D. (. (2026). Anticipating impact of implementing PCV20 or PCV21 vaccines for older adults in the immunisation programme for invasive pneumococcal disease, using nationwide surveillance data, Israel, 2009 to 2024.. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. https://doi.org/10.2807/1560-7917.es.2026.31.15.2500589

Source records

pubmed · retrieved 2026-09-26T08:04:23.624Z